首页> 美国卫生研究院文献>Regenerative Biomaterials >The effect of LyPRP/collagen composite hydrogel on osteogenic differentiation of rBMSCs
【2h】

The effect of LyPRP/collagen composite hydrogel on osteogenic differentiation of rBMSCs

机译:LypRP /胶原复合水凝胶对RBMSCs骨质发生分化的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although platelet-rich plasma (PRP) plays a significant role in the orthopedic clinical application, it still faces two major problems, namely, uncontrollable factors release, frequent preparation and extraction processes as well as the inconvenient form of usage. To overcome these shortcomings, freeze-dried PRP (LyPRP) was encapsulated into bioactive Col I hydrogel to induce osteogenic differentiation of rabbit bone marrow mesenchymal stem cells (rBMSCs). And PRP/Col І composite hydrogel was prepared as a control. Compared with Col І hydrogel, the introduction of platelets significantly improved the mechanical properties of hydrogels. Meanwhile, platelets were evenly distributed in the composite hydrogels network. The sustainable release of related factors in the composite hydrogels could last for more than 14 days to maintain its long-term biological activity. Further cell experiments confirmed that PRP and LyPRP could effectively alleviate the contraction of collagen hydrogel in vitro, and promote the adhesion, proliferation and osteogenesis differentiation of rBMSCs. The results of osteogenic gene expression indicated that the 10% LyPRP/Col І composite hydrogel could facilitate the early expression of BMP-2 and late osteogenic associated protein formation with higher expression of alkaline phosphatase and Osteocalcin (OCN). These results might provide new insights for the clinical application of 10% LyPRP/Col І composite hydrogel as practical bone repair injection.
机译:虽然富含血小板的血浆(PRP)在整形外科临床应用中起着重要作用,但它仍然面临两个主要问题,即无法控制的因素释放,频繁准备和提取过程以及不方便的使用形式。为了克服这些缺点,将冷冻干燥的PRP(LYPRP)包封在生物活性COL I水凝胶中,以诱导兔骨髓间充质干细胞(RBMSCs)的成骨分化。并制备复合水凝胶作为对照的prp / col。与COL4水凝胶相比,血小板的引入显着改善了水凝胶的机械性能。同时,血小板均匀分布在复合水凝胶网络中。复合水凝胶中相关因素的可持续释放可能持续超过14天以维持其长期生物活性。进一步的细胞实验证实,PRP和Lyprp可以有效地减轻体外胶原蛋白水凝胶的收缩,并促进RBMSCs的粘附,增殖和成骨分化。成骨基因表达的结果表明,10%LyprP / Col,复合水凝胶可以促进BMP-2和晚骨化相关蛋白质形成的早期表达,具有更高的碱性磷酸酶和骨钙素(OCN)。这些结果可能为10%LYPRP / COL的临床应用提供新的见解,作为实际骨修复注射的复合水凝胶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号